SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-15-336616
Filing Date
2015-10-02
Accepted
2015-10-02 16:30:51
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d18436df3.htm F-3 363686
2 EX-4.8 d18436dex48.htm EX-4.8 527414
3 EX-5.1 d18436dex51.htm EX-5.1 18051
4 EX-5.2 d18436dex52.htm EX-5.2 11071
5 EX-23.3 d18436dex233.htm EX-23.3 2844
6 GRAPHIC g18436g00y24.jpg GRAPHIC 6924
7 GRAPHIC g18436g87q10.jpg GRAPHIC 12507
8 GRAPHIC g18436g88i24.gif GRAPHIC 1548
  Complete submission text file 0001193125-15-336616.txt   953222
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-207250 | Film No.: 151140759
SIC: 2834 Pharmaceutical Preparations